期刊文献+

前列腺癌患者^(125)I近距离放射治疗后发生急性尿潴留的多因素分析 被引量:1

Multiplicity of acute urinary retention following ^(125)I prostate brachytherapy
下载PDF
导出
摘要 目的分析125I治疗前列腺癌(Brachytherapy)后发生急性尿潴留的各种因素,提出预见性因素,为临床评估及干预提供依据,改进125I植入方法,减少急性尿潴留并发症的发生率。方法我院2008年7月~2011年3月,126例前列腺癌患者行经直肠125I粒子植入,对于发生急性尿潴留的患者,从临床相关,治疗相关两大因素进行综合分析。结果126例125I植入的前列腺癌患者中15例发生了急性尿潴留,均行保留导尿。发生急性尿潴留的时间中位数为植入粒子的第2d(1~7d),保留导尿的时间中位数为7d(4~10d)。单变量分析临床相关,治疗相关因素,再行多因素综合分析,发现穿刺进针数(Number of needles),125I植入前IPSS评分(pre-implant IPSS),植入前前列腺B超体积(pre-implant US prostatevolume),植入125I的粒子数量(number of seeds)与急性尿潴留之间是有统计学意义的(P<0.05),多因素分析number ofneedles,pre-implant IPSS最有意义(P<0.01)。结论 number of needles及pre-implant IPSS可以做为125I近距离放射治疗前列腺癌患者是否发生急性尿潴留的可预见性因素。 Objective To analyze various fctors of acute urinary retention following 125^I prostate brachytherapy and to raise predictive factors.thus,we can provide evidence for clinical assessment and clinical interference.we also can improve implantation method of 125^I brachytherapy to reduce incidence of acute urinary retention.Methods A group of 126 consecutive patients with prostate clinical,treatment-related were evaluated for the need for catheterization owing to urinary retention.Results Fifteen patients(12%) required catheterization.The median time to onset was 2 days after implantation(range 1~7 days).The median duration of catheterization for urinary retention was 7 days(range 4~10 days).Univariate analysis demonstrated that number of needles,pre-implant IPSS,pre-implant US prostate volume and number of seeds were predictive for catheterization.In multivariate analysis,number of needles and pre-implant IPSS were significant indendent priditive factors for catheterization.Conclusion Our data suggest that the number of needles and pre-implant IPSS might be the strongest predictors for catheterization.
出处 《四川医学》 CAS 2012年第7期1109-1111,共3页 Sichuan Medical Journal
基金 四川省卫生厅科研项目(编号:070202)
关键词 急性尿潴留 125I近距离放射治疗 前列腺癌 acute urinary retention 125^I prostate brachytherapy prostate cancer
  • 相关文献

参考文献11

  • 1Blasko JC,Grimm PD,Sylvester JE,et al Palladium-103 braehyther-apy for prostate cancinoma[J].Int J Radiat Oncol Biol Phys,2000,46(4):839-850.
  • 2Han BH,Demel KC,Wallner K,et al.Patient reported complications after prostate brachytheraty[J].J Urol,2001,166(3):953~957.
  • 3Merriek GS,Butler WM,Lief JH,et al.Temporal resolution of urinary morbidity following prostate brachytherapy[J].Int J Radiat Oncol Biol-Phys,2000,47(1):121~128.
  • 4Mallick S,Azzonzi R,Cormier L,et al.Urinary morbidity after 125Ibrachytheraty of the prostate[J].BJU Int,2003,92(6):555-558.
  • 5Nag S,Beyer D,Friedlond J,et al.American brachytherapy society recommendations for transperineal permanent brachythempy of prostate cancer[J].Int J Radiat Oncol Bios Phays,1999,44(4):789~799.
  • 6郭道宁,漆家高,王东,王鸿智,邹晓攀,付光明,辛宇鹏.经直肠超声引导经直肠植入术及其在前列腺癌^(125)I粒子植入中的应用[J].中国超声医学杂志,2009,25(10):980-982. 被引量:11
  • 7Salem N,Simonian-Sauve M.Rosello R,et al.Preditive factors of a-cute urinary morbidity after iodine-125 brachytherapy for localized prostate cancer:a phase 2stady[J].Radiother Oncol,2003,66(2):159~165.
  • 8Crook J.Mclean M.Catton C.et al.Factors influencing risk of acute urinary retention after TURS-guided permanent prostate seed implanta-tion[J].Int J Radiat Oncol Biol Phys,2002.52(2):453~460.
  • 9Bucci J,Morris WJ.Keyes M,et al.Predictive fators of urinary reten-tion following prostate brachytherapy[J].Int J Radiat Oncol Biol Phys,2002,53(1):91-98.
  • 10Terk MD,Stock RG,Stone NN.Identification of patients at increased risk for prolonged urinary retention following radioactive seed implanta-tion ofthe prostate[J].J Urol,1998,160(4):1379~1382.

二级参考文献9

  • 1Nag S, Beyer D, Friedland J, et al. American brachytherapy society recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radfat Onco/ Bios Phys, 1999,44:789-799.
  • 2Merriek GS, Butler WM,Dorsey AT, et al. Rectal function following prostate brachytherapy. Int J Radiat OncoI Biol Phys, 2000,48 (3) :667-674.
  • 3王俊杰,张福君.放射性粒子种植治疗前列腺癌.2版.北京:北京大学医学出版社,2007:228-308.
  • 4Hara R,Jo Y,Fujii T,et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology,2008,71(2) : 191-195.
  • 5Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg,2005,75:48-50.
  • 6Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol, 2001,166 (1) :86-91.
  • 7Pollack A, Horwitz EM, Movsas B, et al. Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment. Urol Clin North Am,2003,30:337-349.
  • 8Gillin MT,Dunning BF, Lawton CA, et al. Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol. Brachytherapy, 2006,5 (3) : 152- 156.
  • 9Lagerburg V, Moerland MA, Lagendijik J J, et al. Measurement of prosate rotation during insertion of needles for brachytherapy. Radiother Oncol,2005,77(3) :318-323.

共引文献10

同被引文献19

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部